皮肤益生素霜与粉刺消护肤霜在治疗痤疮中的比较

观察皮肤益生素霜治疗痤疮的疗效。选择I- IV 度痤疮患者各40 例,共计160 人分二组试用,每组80人。结果使用皮肤益生素霜的患者总有数率为76.2% ,使用粉刺清护肤霜的患者的总有效率为62.5% ,前者与后者相比疗效提高13.3% 。皮肤益生素霜是微生态制剂,以菌治菌,达到消炎的目的。其内含有多种营养成分,作用柔和,宜可长期使用,即治病又可美容     

皮肤益生素霜与美容祛斑霜联合治疗黄褐斑的疗效观察

黄褐斑 (俗称蝴蝶斑 )为淡黄色或褐色不规则的色素沉着斑。好发于额部、两颊、口周等 ,多发生于女性。近年来 ,因为妇女口服避孕药 ,内分泌和消化功能紊乱 ,外出旅游强烈日光照晒 ,使用低劣化妆品等 ,发病率明显增加。因有碍美观 ,已成为爱美女士的一块“心病”。临床求治的患者明显增加 ,约占皮肤美容护理患者的 31% ,无论在皮肤科还是在美容界中 ,都感到治疗困难。自 1998年以来 ,我们将皮肤益生素霜与美容祛斑霜联合使用治疗黄褐斑 ,取得了一定的疗效 ,现报告如下 :1　材料与方法1.1　临床资料　 83例患者均为女性 ,随机分两组。美容祛斑…     

蛇毒霜治疗寻常痤疮

蛇毒霜是东北陆生白眉蝮蛇毒制剂清栓酶之外用剂型,自1987年以来.我们自制该药外用治疗寻常痤疮72例,疗效满意,报告如下:1 临床资料:本组72例中,男性50例,女性22例。年龄17～30岁.病程半年～4年.损害多为散在丘疹或脓疮,有黑头粉刺,皮损以面部为主.2 治疗方法:用温水洗净患处皮肤,将蛇毒霜均匀涂抹于患处一薄层,每日3～4次,15天为一疗程.治疗期间停用其它化妆品和药膏。3 治疗效果:疗效判定标准参照中国人民解放军总后勤部卫生部编《临床疾病诊断依据好转标准》中有关内容.分为治愈、好转及无效.     

健康人和黄褐斑患者皮损区菌群的探讨

黄褐斑是常见损容性的色素沉着性皮肤病,其病因及发病机制比较复杂,一般认为与妊娠、口服避孕药、某些慢性病、化妆品中的光敏物质、遗传因素及紫外线等有关.随着皮肤微生态学的兴起,近年来国内有人用微生态制剂治疗黄褐斑.该研究小组通过定位、定量、定性的方法对58例黄褐斑患者皮损区和58例健康人面部菌群进行研究比较,旨在探讨黄褐斑患者皮损处微生态的改变并为开展微生态治疗提供试验依据.     

皮炎平联合Y形纱布敷料治疗PICC置管局部皮肤过敏的效果观察

目的观察皮炎平联合Y形纱布敷料治疗PICC置管局部皮肤过敏的效果。方法对我科行PICC置管导致局部皮肤过敏患者20例,采用生理盐水棉球清洗后予氯乙啶消毒皮肤后再用生理盐水棉球清洗一遍待干,然后在皮疹部位均匀涂抹皮炎平软膏,并给予Y形纱布敷料固定。结果经皮炎平联合Y形纱布敷料治疗后,痊愈13例,显效4例,有效2例,无效1例,总有效率95%。结论采用皮炎平联合Y形纱布敷料治疗PICC置管局部皮肤过敏的效果良好,且导管固定牢靠,无脱管、进管现象。     

口服特比萘芬联合外用药治疗皮肤浅部真菌病137例

目的观察口服特比萘芬联合外用药治疗皮肤浅部真菌病的疗效。方法对137例皮肤浅部真菌病患者应用特比萘芬口服1周(250mg/d)联合外用咪康唑霜1周治疗,观察其临床疗效。结果痊愈126例,显效4例,好转7例,无效0例。总有效率为94.9%,真菌清除率为95.6%。结论口服特比萘芬联合咪康唑霜外用治疗皮肤浅部真菌病有良好的疗效。     

全面护理干预在异位妊娠保守治疗中的应用效果研究

目的分析对异位妊娠患者实施保守治疗时应用全面护理模式的效果。方法选取我院妇产科2013.5~2015.9治疗的50例异位妊娠患者作为研究对象,分为全面干预组、对照组,每组25例,对照组的护理方法为一般性辅助护理,全面干预组的护理方法包括心理护理、并发症预防护理等。结果全面干预组中治愈16例,有效8例,无效1例;对照组中治愈10例,有效9例,无效6例。结论在对异位妊娠患者进行保守治疗时应用全面护理模式能够改善临床疗效。     

痤疮皮损区皮肤菌群的研究

本研究对皮肤常见病─—痤疮４０例病人皮损区的皮肤菌群进行了探讨,并以１０４例健康人面部皮肤菌群及８２例治愈后病人原皮损区菌群分析作为对照,结果痤疮病人皮损区中痤疮丙酸杆菌活菌数为４．５５±０．７３（ＣＦＵ以Ｌｏｇ／ｃｍ２计）。分离率为１００％,表皮葡萄球菌数为４．１９±０．７０（１００％）,微球菌数为２．７１±０．６９（６２．５％）,杆菌数为３．０９±０．６４（９０％）,需氧的革兰氏阴性杆菌数为３．３１±０．７６（３５％）,产色素微球菌数为３．０５±０．８２（４５％）,痤疮病人皮肤的皮损区内常住菌和过路菌都较健康人明显增加,差异显著（Ｐ＜０．０５或Ｐ＜０．０１）。而经皮肤微生态制剂治疗后痤疮病皮肤菌群与健康人几乎无差异（Ｐ＞０．０５）,说明皮肤微生态制剂具有调整皮肤菌群恢复微生态平衡,提高定植抗力的生理作用,故能较有效的治疗痤疮。     

微等离子体射频技术治疗成熟瘢痕50例临床观察

目的:研究新型微等离子体射频技术治疗瘢痕的效果。方法:50例成熟瘢痕患者,包括31例痤疮疤痕,19例外伤或手术疤痕。均采用微等离子体射频技术进行功率为70～90Watt的滑动式或定点式治疗,每4周治疗一次,共治疗2～5次,通过治疗前及治疗后3个月统一衡量标准对比来进行疗效评估。结果:成熟瘢痕表现为身体各部位分布形状不规则形状皮肤组织凹陷或轻度增生。通过临床指标评分,50例患者总有效率为82%。疗效显著18例(36%),有效22例(44%),轻微改善11例(22%),无效9例(18%)。结论:微等离子体射频技术能显著改善成熟瘢痕的色泽、质地和凸凹程度,不良反应少,是治疗成熟瘢痕的有效方法。     

磁疗在美容中的应用

利用磁场美容,是使用磁珠、磁片、磁环、磁疗机等磁具及磁化水进行美容。采用的磁珠是直径2mm,磁场强度为0.4～1mT的医用磁珠,磁片和磁环是不同大小尺寸、不同磁场强度的医用钕铁硼磁片和磁环。美容的范围包括治疗黄褐斑、面部血管瘤、痤疮、脱发、减肥及皮肤的保养等。治疗黄褐斑患黄褐斑女性较多,男性也有。发病部位在前额、颊部、鼻部、颧部、口部周围等处,左右呈对称状,损害为淡褐色至深褐斑片,界限清楚略像蝴蝶形,是一种后天性,局限性皮肤黑色素增多疾病。可能与内分泌功能紊乱、月经不调、日晒及慢性病等诱使局部皮肤黑色素细胞亢进…     

Superinfections of the Lung: An Evaluation for Serial Transtracheal Aspirations

A prospective evaluation of cephaloridine, cephalothin, and lincomycin was conducted in 85 patients with pneumonia. None of the 50 with previous history of allergic sensitivity to penicillin had an allergic reaction. All cases of pure “pneumococcal pneumonia” were cured, regardless of the drug. Eight patients with polymicrobial pneumonia were cured by the cephalosporins, while lincomycin was ineffective in four patients who had polymicrobial pneumonia.Although expectorated sputum and exudates from the nasopharyngeal and oropharyngeal areas contained large concentrations of Staphylococcus aureus and various Gram-negative bacillary species during and at the end of therapy, serial cultures of transtracheal aspirate and the clinical course failed to confirm “superinfection” of the lung.     

鼻内镜手术治疗慢性鼻窦炎54 例临床疗效分析

目的:研究鼻内镜手术治疗慢性鼻窦炎的疗效。方法:选取在2008年10月至2010年1月之间来本院进行手术治疗的慢性鼻窦炎患者54例,使用鼻内镜手术进行治疗,作为此次研究的治疗组;而同时选取在同一时期来到本院的38例患者,作为此次研究的对照组采用一般的鼻外径手术治疗。在手术结束以后每位患者均需随访1年,根据患者的恢复情况比较两种手术方法对鼻窦炎的疗效,以上手术方式均根据患者意愿。结果:使用鼻内镜手术进行治疗的患者中治愈的有31例,有效的有18例,而无效的则有5例,总的有效率为90.7%;而采用一般手术的患者中治愈的患者为17例,有效的患者为12例,无效的则有9例,其总的有效率为76.3%;且应用鼻内镜手术的治疗组的并发症发生率小于使用一般手术的对照组,两组患者疗效比较差异有统计学意义(P<0.05)。结论:鼻内镜手术治疗慢性鼻赛炎的疗效确切,安全可靠,值得广大医务工作者在临床上大力推广。     

CYTOLOGY OF THE POSTNASAL DRIP

About half of a series of 100 consecutive patients with disturbances of the eyes, ears, nose or throat complained of postnasal drip. When smears of the mucous discharge were examined it was found that in about a third of the cases in which there was complaint of drip, neither eosinophils nor neutrophils could be demonstrated. This indicates that causes of the drip other than allergic disease and infection must be considered.Cytologic examination of the postnasal drip showed that about one-third of the patients with nasal disease or histories positive for allergic reaction had nasal eosinophilia. Nasal eosinophilia was noted occasionally in patients with normal-appearing nasal structures and in patients with no history of allergic disease.     

依达拉奉联合克林澳对急性脑梗死患者血清MMP-3、MMP-9、TIMP-1、EPCs的影响及疗效观察

目的:研究依达拉奉联合克林澳对急性脑梗死患者血清MMP-3(基质金属蛋白酶-3)、MMP-9(基质金属蛋白酶-9)、TIMP-1(组织基质金属蛋白酶抑制剂1)、EPCs(内皮祖细胞)的影响及疗效观察。方法:选取我院收治的114例急性脑梗死患者,按照随机数表法分为联合治疗组(n=57)和单独治疗组(n=57)。单独治疗组仅应用依达拉奉治疗,联合治疗组则联合克林澳治疗。观察并比较两组患者临床治疗效果、NIHSS(美国国立卫生研究院卒中量表)评分变化情况、实验室指标水平变化情况、血脂水平变化情况以及不良反应发生情况。结果:治疗后,联合治疗组基本痊愈和显著进步的患者达到49例,其总有效率为85.96%,而单独治疗组基本痊愈和显著进步的患者仅为39例,其总有效率为68.42%,两组比较差异显著(P0.05)。治疗14 d和28 d后,患者的评分均较治疗前有明显下降,同时,联合治疗组下降水平明显优于单独治疗组(P0.05)。两组患者MMP3和MMP9水平较治疗前显著下降,而TIMP-1和EPCs水平则明显上升,且联合治疗组MMP3和MMP9水平下降情况和TIMP-1和EPCs水平上升情况均明显优于单独治疗组(P0.05)。治疗14 d和28 d后,患者血脂各指标水平均较前一次测量有明显下降,且单独治疗组较联合治疗组下降更为明显(P0.05)。联合治疗组不良反应发生率为5.26%;单独治疗组不良反应发生率为10.53%,不良反应发生率比较无统计学意义(P0.05)。结论:依达拉奉联合克林澳应用于治疗急性脑梗死患者疗效确切,有效改善血清MMP-3、MMP-9、TIMP-1、EPCs以及患者血脂异常情况,促进血管新生,保护患者脑组织。     

孟鲁司特钠对过敏性鼻炎患者血清IL-5和IL-10水平的影响及安全性分析

目的:分析孟鲁司特钠对过敏性鼻炎患者血清白细胞介素-5(IL-5)及白细胞介素-10(IL-10)水平的影响及安全性。方法:选择我院2015年10月~2016年10月收治的106例过敏性鼻炎患者,按不同治疗方式分作对照组与研究组,每组53例。对照组选用氯雷他定片治疗;研究组在对照组基础上加以孟鲁司特钠治疗。观察并比较两组患者的临床疗效、治疗前后血清IL-5及IL-10水平变化、症状及体征积分及不良反应发生情况。结果:研究组总有效率(94.33%)高于对照组(79.24%)(P0.05)。治疗后,两组血清IL-5,症状及体征积分均显著下降,研究组下降更明显,两组血清IL-10均有显著上升,研究组上升更明显,差异均有统计学意义(P0.05)。两组不良反应发生情况比较,差异无统计学意义(P0.05)。结论:孟鲁司特钠能够调节过敏性鼻炎患者血清炎症因子水平,降低症状积分,且安全性较高。     

三种不同皮瓣修复口腔颌面组织缺损的临床效果

目的:探讨三种皮瓣在口腔面部组织缺损修复中的临床效果。方法:以2014年1月到2014年12月在我院皮瓣修复口腔面部组织缺损患者64例为研究对象。胸大肌皮瓣26例,前臂皮瓣22例,股前外侧皮瓣16例。术后3~12月对患者临床疗效进行观察评价。结果:患者均采用胸大肌皮瓣、股前外侧皮瓣和前臂皮瓣进行口腔面部组织缺损的修复,不同皮瓣来源数量组间比较差异均无统计学意义(P0.05)。患者术后均治愈,移植成功率100%,组间比较差异无统计学意义(P0.05)。少数患者发生积血、感染不良反应情况,总不良反应发生率为12.5%,不同组间的不良反应发生率比较差异无统计学意义(P0.05)。结论:三种不同的皮瓣修复口腔面部组织缺损临床效果均较好,皮瓣的选择较广泛,显著改善了患者口腔生理功能,提高了患者的生活质量,临床推广使用价值高。     

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome.

Monocycline is the most widely prescribed systemic antibiotic for acne largely because it needs to be given only once or twice a day and seems not to induce resistance. Up to April 1994 11 cases of minocycline induced systemic lupus erythematosus and 16 cases of hepatitis had been reported to the Committee on Safety of Medicines. An analysis of these cases together with seven other cases shows the severity of some of these reactions. Two patients died while taking the drug for acne and a further patient needed a liver transplant. Acne itself can induce arthritis and is often seen in association with autoimmine liver disease, but the clinical and biochemical resolution seen after withdrawal of the drug, despite deterioration of the acne, suggests a drug reaction. In five cases re-exposure led to recurrence. Because reactions may be severe early recognition is important to aid recovery and also to avoid invasive investigations and treatments such as corticosteroids and immunosuppresants. Safer alternatives should be considered for treating acne.     

大剂量降纤酶治疗急性脑梗死的临床研究

目的 探讨大剂量降纤酶治疗急性脑梗死的临床疗效及作用机制。方法 将收治的90例发病在72h内的急性脑梗死患者随机分为大剂量降纤酶组（A组）、中等剂量降纤组（B组）、丹参注射液治疗组（C组）,每组各为30例,A组每天给予降纤酶20u加入0.9%氯化钠注射液250ml中静滴1h以上,每天1次,连用3天,总剂量60u;B组每天用降纤酶10u,连用3天,总剂量30u;C组给予丹参注射液20ml加入5％葡萄糖注射液250ml中静滴,每天1次,连用7天。3个组在用药前后以神经功能缺损程度为指标进行评价,并观察治疗前后血液流变学变化。结果 A组总有效率96．7％,显效率90％,优于B组（总有效率80％,显效率63．3％）,明显优于C组（总有效率60％,显效率33．3％）。A组、B组治疗后血纤维蛋白原明显降低,血粘度得到改善,且A组优于B组。结论 大剂量降纤酶治疗急性脑梗死疗效优于中等剂量降纤酶和常规药物。其主要机制是降低血纤维蛋白原,改善血粘度,从而改善了微循环;增强t-PA,溶解血栓。该药安全可靠,未见自发性出血症状和过敏反应,对肝、肾功能、凝血功能无明显影响,随访3个月稳定性好。     

Contact allergy caused by fragrance mix and Myroxylon pereirae (balsam of Peru)--a retrospective study

Because of their widespread use, fragrances are among the most common causes of contact allergic dermatitis, second only to nickel. During a five-year period 3,065 patients with contact dermatitis were patch tested using a specific mix of fragrances. 509 (16.6%) patients were allergic to the fragrance mix, while 258 (8.4%) patients exhibited an allergic reaction to Myroxylon pereirae (balsam of Peru). Between those 509 patients, 157 were patch tested with eight individual substances contained in the fragrance mix: cinnamal, cinnamyl alcohol, eugenol, isoeugenol, geraniol, hydroxycitronellal, alpha-amyl cinnamal and Evernia prunastri (oak moss). The most frequent allergens were isoeugenol 57.9% (91/157), eugenol 55.4% (87/157), cinnamyl alcohol 34.4% (54/157) and Evernia prunastri (oak moss) 24.2% (38/157). There were 62 patients (39.5%) who exhibited an allergic reaction to both the fragrance mix and Myroxylon pereirae (balsam of Peru). The results prove the importance of avoiding allergens in daily life, especially in industrial and cosmetic products. In order to prevent ACD, better cooperation between industry and dermatologists is needed.     

Plasmodium falciparum: drug-resistant malaria complicating leukemias and lymphomas in children.

The present communication deals with drug-resistant Plasmodium falciparum malaria complicating hematologic malignancies (leukemias, n = 24, and lymphomas, n = 7) in children. Of 50 cases of hematologic malignancies, 31 patients were microscopically diagnosed as having P. falciparum infection (MP +). Initially, all the patients were treated with chloroquine. The results of primary treatment showed chloroquine resistance in 16 (51. 62%) cases. Of these 16 chloroquine-resistant cases, 13 were secondarily treated with a combination of pyrimethamine plus sulfamethopyrazine. The results of secondary treatment also revealed resistance to pyrimethamine plus sulfamethopyrazine in 6 of 13 (46. 10%) cases. The 6 pyrimethamine plus sulfamethopyrazine-resistant P. falciparum cases were finally cured by quinine therapy, against which no resistance was encountered. Conversely, in the control group comprising 38 cases of P. falciparum without malignancy, the incidence of chloroquine resistance was found in only 9 cases, which is rather low (23.70%). Of these 7 chloroquine-resistant cases, 5 were found to be sensitive to pyrimethamine plus sulfamethopyrazine treatment, while the 2 nonresponders were finally cured with quinine. The overall results of this study show a high prevalence of chloroquine resistance among clinical cases of falciparum malaria (25/69; 30.6%). Among the nonresponders (n = 20) 40% of cases were also resistant to the pyrimethamine plus sulfamethopyrazine combination. There was no resistance to quinine.